Increased government focus on metabolic disease management and strategic investment by global pharma companies are accelerating product launches and adoption across the region
While the primary symptom is intense abdominal pain, it can sometimes be accompanied by digestive changes that affect the stool
Systemic options like dupilumab [20] and tralokinumab are approved by FDA for moderate-to-severe cases, however age limitations occur [21]
We suggest eating smaller, frequent meals to sustain energy levels and manage hunger effectively
Familiarizing Yourself with GLP-1 Medications | Video Blog Part 1 Ozempic, Wegovy, Mounjaro - these weight loss meds are conversation starters for a reason
Lalli M, Brouillette K, Kapczinski F, de Azevedo Cardoso T